Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2096978 Target Snapshot

Thioredoxin reductase · PROTEIN FAMILY · Homo sapiens

113Compounds
68Assays
0Approved Drugs
148.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q16881. Use UniProt Q16881 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q16881 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Thioredoxin reductase as ChEMBL target CHEMBL2096978, mapped to UniProt Q16881. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Thioredoxin reductase
PROTEIN FAMILY · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2096978
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q16881
Thioredoxin reductase 1, cytoplasmic
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Thioredoxin reductase is the right protein anchor across sources, using UniProt Q16881 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelThioredoxin reductase 1, cytoplasmic
UniProt AccessionQ16881
Component TypeProtein
Sequence Length649 aa

Thioredoxin reductase 1, cytoplasmic

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Thioredoxin reductase, mapped to UniProt Q16881. ChEMBL maps the protein component as Thioredoxin reductase 1, cytoplasmic. Sequence length is 649 aa.

Mapped IDQ16881
Review nameThioredoxin reductase
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Phase III
1
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC50147.0
KI1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL120147 7.75 IC50 18.0 Preclinical
CHEMBL217200 6.58 IC50 260.0 Preclinical
CHEMBL3814977 6.55 Ki 280.0 Preclinical
CHEMBL88230 6.46 IC50 350.0 Preclinical
CHEMBL412348 6.3 IC50 500.0 Preclinical
CHEMBL413290 5.92 IC50 1200.0 Preclinical
CHEMBL4451948 5.91 IC50 1220.0 Preclinical
CHEMBL3290761 5.85 IC50 1400.0 Preclinical
CHEMBL385299 5.8 IC50 1600.0 Preclinical
CHEMBL440625 5.8 IC50 1600.0 Preclinical
Distribution

pChEMBL Value Distribution

23
5.0
15
5.5
2
6.0
3
6.5
0
7.0
1
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

86
Total Assays
45
Tested Compounds
2
Assay Types
Binding — 71 assays, 45 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 37 11 5.4
protein format 34 34 5.2
Functional — 15 assays, 16 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 15 16 5.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine